REFERENCES
- Azarkeivan A, Ahmadi MH, Hajibeigi B, . Evaluation of transfusion reactions in thalassemic patients referred to the Tehran Adult Thalssemia Clinic. J Zanjan Faculty Med. 2008;1):35–41.
- Froutan-Pishbijari H, Ghofrani H, Mirmomenm S, . Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls. Med Sci Monit. 2004;10:CR679–CR683.
- Buxton JA, Kim JH. Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: a review of the evidence and current recommendations. Can J Infect Dis Med Microbiol. 2008;19:197–202.
- Mazumder M, Sengupta B, De M, Lahiri P, Bhattacharya DK. Immunosurveillance of transfusion dependent thalassaemia and hepatitis B vaccination. J Assoc Physicians India. 1993;41:342–344.
- Dentico P, Buongiorno R, Volpe A, . Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients. Infection. 1992;20:276–278.
- Azarkeivan A, Karimi Gh, Shaigan M, . Antibody titration and immune response of Iranian β-thalassemic patients to hepatitis B virus vaccine (booster effect). Pediatr Hematol Oncol. 2009;26:195–201.
- Singh H, Pradhan M, Singh RL, . High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions. Vox Sang. 2003;84:292–299.
- Feitelson M, Lega L, Guo J, . Pathogenesis of posttransfusion viral hepatitis in children with beta-thalassemia. Hepatology. 1994;19:558–568.